Becton, Dickinson uses rating-sensitive bridge for Bard takeover

© 2025 GlobalCapital, Derivia Intelligence Limited, company number 15235970, 4 Bouverie Street, London, EC4Y 8AX. Part of the Delinian group. All rights reserved.

Accessibility | Terms of Use | Privacy Policy | Modern Slavery Statement | Event Participant Terms & Conditions

Becton, Dickinson uses rating-sensitive bridge for Bard takeover

bridgez_fotolia_230x150

Becton, Dickinson and Co, the US medical devices group, has obtained a $15.7bn bridge loan for its $24bn buyout of CR Bard, a rival in the same industry. The margin will depend on whether BD can hold on to its credit ratings.

Unlock this article.

The content you are trying to view is exclusive to our subscribers.

To unlock this article:

Request a Free Trial or Login
Gift this article